Vivani Medical, Inc. financial data

Symbol
VANI on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
1350 S. Loop Road, Alameda, CA
State of incorporation
CA
Fiscal year end
December 31
Former names
SECOND SIGHT MEDICAL PRODUCTS INC (to 8/18/2022), SECOUND SIGHT MEDICAL PRODUCTS INC (to 10/10/2003)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 428 % -25%
Debt-to-equity 108 % +127%
Return On Assets -49.2 % +4.61%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.2M shares +16.1%
Common Stock, Shares, Outstanding 55.3M shares +108212%
Entity Public Float 38.9M USD
Common Stock, Value, Issued 109M USD -68.7%
Weighted Average Number of Shares Outstanding, Basic 55.2M shares +8.68%
Weighted Average Number of Shares Outstanding, Diluted 55.2K shares +8.68%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.2M USD -3.22%
General and Administrative Expense 8.28M USD -30.2%
Operating Income (Loss) -24.4M USD +14.4%
Net Income (Loss) Attributable to Parent -23.5M USD +12.8%
Earnings Per Share, Basic -0.11 USD/shares +15.4%
Earnings Per Share, Diluted -0.11 USD/shares +15.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.6M USD -20.8%
Assets, Current 21.4M USD -30.3%
Property, Plant and Equipment, Net 1.64M USD +45%
Operating Lease, Right-of-Use Asset 18.4M USD -8.31%
Other Assets, Noncurrent 1.34M USD -2.05%
Assets 42.9M USD -19.5%
Accounts Payable, Current 815K USD -56.9%
Employee-related Liabilities, Current 371K USD -45.1%
Accrued Liabilities, Current 2.02M USD +11.5%
Contract with Customer, Liability, Current 335K USD 0%
Liabilities, Current 6.27M USD -15.6%
Operating Lease, Liability, Noncurrent 18.3M USD -7.04%
Liabilities 24.6M USD -9.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 92K USD +100%
Retained Earnings (Accumulated Deficit) -116M USD -25.4%
Stockholders' Equity Attributable to Parent 18.3M USD -30%
Liabilities and Equity 42.9M USD -19.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.51M USD +35.2%
Net Cash Provided by (Used in) Financing Activities 13.7M USD
Net Cash Provided by (Used in) Investing Activities -182K USD -392%
Common Stock, Shares Authorized 300M shares
Common Stock, Shares, Issued 55.3M shares +108212%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.99M USD
Deferred Tax Assets, Valuation Allowance 60.9M USD +11%
Deferred Tax Assets, Gross 63M USD +11.4%
Operating Lease, Liability 19.7M USD
Payments to Acquire Property, Plant, and Equipment 182K USD +392%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.4M USD +12.8%
Lessee, Operating Lease, Liability, to be Paid 28.5M USD
Property, Plant and Equipment, Gross 4.19M USD +10%
Operating Lease, Liability, Current 1.39M USD +0.65%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.89M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 2.91M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.8M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.98M USD
Deferred Tax Assets, Operating Loss Carryforwards 184M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.69M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.07M USD
Operating Lease, Payments 30M USD
Additional Paid in Capital 134M USD +13.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 99K USD -8.33%
Share-based Payment Arrangement, Expense 1.85M USD +39.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%